Useful Article On Cornell Ivf
Cornell Ivf Article
This is a selection made from among articles on Cornell Ivf. For a permanent link to this article, or to bookmark it for future reading, click here.
Cheap IVF Procedures: the Technique Lies in Simplicity
from:The desire to conceive a child is the ultimate hope for most infertile couples. For years, this desire was never fulfilled. Yet, now that technologies are rapidly developing, new techniques are produced to address this need for assisted fertilization. One method is in vitro fertilization.
This process works by stimulating the ovaries to produce multiple eggs to be retrieved when their maturity comes. Afterwhich, the egg cells will be retrieved while the sperm cells will be collected from the male participant. These cells will then be combined in the laboratory to help induce fertilization. Depending on the in vitro fertilization clinic, the fertilization will take some 2 to 5 days of incubation. Afterwards, the fertilized egg will be transplanted into the woman's womb.
This intricate process will conclude at the embryo transfer, a procedure that is much simpler than the egg retrieval. Although the description sounds easy, it still does not negate the fact that the complexities of in vitro entails a number of risks that will increase in time.
Although in vitro fertilization has become popular in recent years, there are still hung-ups why infertile couples do not go straight to using the method. One of the most revealing factor is the price. Only because the procedure entails the use of high technologies, the prices have become considerably expensive. Anything that is complex is bound to be pricey. This is especially true in the developing world.
While Westerners can afford the treatment, it is usually counterproductive for third world countries wherein physicians normally copy methods used in other countries. Imitating western methods may mean coping with the high costs. Even if these methods have gained so much success, they would still be impractical for those who would have to spend all their lifetime's earnings just to afford a cycle that cannot guarantee them initial success. Another issue that makes in vitro more costly in the developing world is the unavailability of the technology to support the service. Thus, they would have to import from foreign countries, which then would double up the price.
To at least gain some solution to this problem, physicians (or is it the technology itself?) moved to two different directions. One leads to sophistication while the other leads to simplicity.
While simplified methods often lead to failed attempts, we still cannot deny the truth that over-all patients would only have to pay less for a cheap IVF procedures. Remember that the only thing which makes in vitro fertilization pricey are the extensive measures that physicians use to ensure higher success rates for pregnancy.
If a couple can afford to make several attempts of cheap IVF procedure with failures on the initial cycles, then their chance of pregnancy may equal to that of the more elaborate procedures that require higher payment. But this proposal will need to be accepted as something that borders on the trial and error principle.
With as much trial as one may afford with cheap IVF procedure the cost effectiveness of the procedure will still equal the benefits of those that are used in Western countries. Remember that even such procedures do not guarantee that the first attempt will yield a successful birth. Even those who can afford conventional in vitro fertilization would still have to face the possibility of miscarriage and birth defects in the child.
However, with cheap IVF procedures, the patients will have to apply for several attempts. This is because the success rate for each attempt is rather low due to the absence of refined methods that will ensure higher success. Nonetheless, they will still spend lesser in the long run. More importantly, cheap IVF procedures can ensure that even those who are not financially secured can still avail of the service.
 |
 |
Cornell Ivf News
Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology
Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases confirmed that testing of two (2) of the company's compounds Onconase (Ranpirnase), and recombinant Amphinase 2 showed positive in vitro results for Severe Acute Respiratory Syndrome, also known as (SARS) virus.
Read more...